Open AccessTrial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis
Author(s) -
Luca Richeldi,
Arata Azuma,
Vincent Cottin,
Christian Heßlinger,
Susanne Stowasser,
Claudia Valenzuela,
Marlies Wijsenbeek,
Donald F. Zoz,
Florian Voß,
Toby M. Maher
Publication year - 2022
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa2201737
Subject(s) - idiopathic pulmonary fibrosis , pulmonary fibrosis , phosphodiesterase inhibitor , phosphodiesterase , medicine , cgmp specific phosphodiesterase type 5 , pharmacology , chemistry , fibrosis , lung , sildenafil , biochemistry , enzyme
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom